Reactivation with Hepatitis B: Understanding Risk Factors and
Charting a new frontier in chronic hepatitis B research to improve
Position paper
A global scientific strategy to cure hepatitis B
VIDEO
Interview with Prof. Dr. Ulrike Protzer, International HBV Meeting
Is Hepatitis B virus Curable ? #drmerish #siddhamedicine
Hepatitis B patient handling by Nurses? #hepatitisawareness #hbsag
Dr. Norah Terrault
Risk factors of HBV infection in North Ethiopia
Round Table Discussion:Research of Hepatitis B Virus Disease in the US: NIDDK Hep B Research Network
COMMENTS
Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy
The core antibody to hepatitis B virus (anti-HBc) can be detected through immunoassays for total anti-HBc, which is able to detect both anti-HBc IgG and anti-HBc IgM. Anti-HBc IgM is the determinant of acute hepatitis B and is often the only sign that may be detected during the period of acute hepatitis B when HBsAg has become undetectable.
Hepatitis B Virus: From Diagnosis to Treatment
Abstract. Hepatitis B infection is still a global concern progressing as acute-chronic hepatitis, severe liver failure, and death. The infection is most widely transmitted from the infected mother to a child, with infected blood and body fluids. Pregnant women, adolescents, and all adults at high risk of chronic infection are recommended to be ...
New Approaches to Chronic Hepatitis B
DOI: 10.1056/NEJMra2211764. VOL. 388 NO. 1. Chronic hepatitis B is caused by the hepatitis B virus (HBV), a hepatotropic DNA virus that can replicate at high levels and cause minimal disease or ...
Hepatitis B
Hepatitis B virus (HBV) infection is a major public health problem, with an estimated 296 million people chronically infected and 820 000 deaths worldwide in 2019. Diagnosis of HBV infection requires serological testing for HBsAg and for acute infection additional testing for IgM hepatitis B core antibody (IgM anti-HBc, for the window period when neither HBsAg nor anti-HBs is detected).
Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy
In the United States, by CDC estimates, only one-third of HBV-infected patients or less are aware of their infection. Some reasons for these low rates of surveillance, diagnosis, and treatment include the asymptomatic nature of chronic hepatitis B until the very late stages, a lack of curative therapy with a finite treatment duration, a complex ...
Hepatitis B
Research Highlights 22 Mar 2024 Nature Reviews Gastroenterology & Hepatology. Volume: 21, P: 300. ... Vaccination is a key intervention for the elimination of hepatitis B virus (HBV) and hepatitis ...
Global, regional, and national burden of hepatitis B, 1990-2019: a
The prevalence of chronic HBV infection declined over time, particularly in children younger than 5 years, since the introduction of hepatitis B vaccination. HBV-related death rates also decreased, but HBV-related death counts increased as a result of population growth, ageing, and cohort effects. By 2019, many countries had met the interim seroprevalence target for children younger than 5 ...
Immunobiology and pathogenesis of hepatitis B virus infection
Abstract. Hepatitis B virus (HBV) is a non-cytopathic, hepatotropic virus with the potential to cause a persistent infection, ultimately leading to cirrhosis and hepatocellular carcinoma. Over the ...
Global burden of hepatitis B virus: current status, missed
Chronic hepatitis B virus (HBV) infection affects about 296 million people worldwide and is the leading aetiology of cirrhosis and liver cancer globally. ... Breakthroughs in hepatitis C research ...
Review article: hepatitis B-current and emerging therapies
Background: The hepatitis B virus (HBV) affects an estimated 290 million individuals worldwide and is responsible for approximately 900 000 deaths annually, mostly from complications of cirrhosis and hepatocellular carcinoma. Although current treatment is effective at preventing complications of chronic hepatitis B, it is not curative, and often must be administered long term.
Current Challenges and Future Perspectives of Diagnosis of Hepatitis B
1. Introduction. Hepatitis B virus (HBV) infection remains a major health problem despite an extensive vaccination program worldwide. Globally, 260 million people are chronically infected with HBV and 890,000 are dying yearly from complications due to the advancement of HBV infection [1,2].HBV may play a role in the pathogenesis of chronic liver disease, cirrhosis, and hepatocellular carcinoma ...
PDF Hepatitis B
Wen-Juei Jeng, George V Papatheodoridis, Anna S F Lok. Hepatitis B virus (HBV) infection is a major public health problem, with an estimated 296 million people chronically infected and 820 000 deaths worldwide in 2019. Diagnosis of HBV infection requires serological testing for HBsAg and for acute infection additional testing for IgM hepatitis ...
Closing in on a cure for hepatitis B
For Thomas Tu, eliminating hepatitis B is a deeply personal goal. Tu, a molecular virologist at the Westmead Institute for Medical Research in Sydney, Australia, learnt he had chronic hepatitis B ...
A systematic review of hepatitis B virus (HBV) drug and vaccine ...
Author summary The Global Hepatitis Health Sector Strategy is aiming for the elimination of viral hepatitis as a public health threat by 2030. However, mutations associated with drug resistance and vaccine escape may reduce the success of existing treatment and prevention strategies. In the current literature, the prevalence, distribution and impact of hepatitis B virus (HBV) mutations in many ...
Journal Articles on Hepatitis B Research, Vaccination and Public
Hepatitis B Foundation releases white paper calling health care providers into action following new hepatitis B screening and vaccination recommendations ; ... Anonymous donor provides record gift for hepatitis B research; Two hepatitis B medications available free through Hepatitis B Foundation and Rx Outreach partnership;
Hepatitis B virus
Hepatitis B virus is an infectious agent that causes hepatitis B, a type of liver inflammation in humans. A vaccine exists against this virus species. Latest Research and Reviews
Hepatitis B virus infection and associated risk factors among ...
Background Hepatitis B virus (HBV) is a highly contagious pathogen that has become a severe public health problem and a major cause of morbidity and mortality, particularly in developing countries. Medical students are at high occupational risk during their training. However, no facility-based studies were found among medical students in eastern Ethiopia. Thus, this study aimed to investigate ...
A global scientific strategy to cure hepatitis B
The HBV cure research agenda outlined in this position paper will contribute markedly to the goal of eliminating HBV infection worldwide. ... Despite the huge human and economic toll of chronic hepatitis B, 2 HBV research remains largely underfunded, 5 to the point of recently being compared to a neglected tropical disease. 6 Given recent ...
Research round-up: hepatitis B
Hepatitis B infections are a major cause of hepatocellular carcinoma (HCC), which kills more than 700,000 people globally every year. The virus drives cancer by rearranging human chromosomes ...
IMAGES
VIDEO
COMMENTS
The core antibody to hepatitis B virus (anti-HBc) can be detected through immunoassays for total anti-HBc, which is able to detect both anti-HBc IgG and anti-HBc IgM. Anti-HBc IgM is the determinant of acute hepatitis B and is often the only sign that may be detected during the period of acute hepatitis B when HBsAg has become undetectable.
Abstract. Hepatitis B infection is still a global concern progressing as acute-chronic hepatitis, severe liver failure, and death. The infection is most widely transmitted from the infected mother to a child, with infected blood and body fluids. Pregnant women, adolescents, and all adults at high risk of chronic infection are recommended to be ...
DOI: 10.1056/NEJMra2211764. VOL. 388 NO. 1. Chronic hepatitis B is caused by the hepatitis B virus (HBV), a hepatotropic DNA virus that can replicate at high levels and cause minimal disease or ...
Hepatitis B virus (HBV) infection is a major public health problem, with an estimated 296 million people chronically infected and 820 000 deaths worldwide in 2019. Diagnosis of HBV infection requires serological testing for HBsAg and for acute infection additional testing for IgM hepatitis B core antibody (IgM anti-HBc, for the window period when neither HBsAg nor anti-HBs is detected).
In the United States, by CDC estimates, only one-third of HBV-infected patients or less are aware of their infection. Some reasons for these low rates of surveillance, diagnosis, and treatment include the asymptomatic nature of chronic hepatitis B until the very late stages, a lack of curative therapy with a finite treatment duration, a complex ...
Research Highlights 22 Mar 2024 Nature Reviews Gastroenterology & Hepatology. Volume: 21, P: 300. ... Vaccination is a key intervention for the elimination of hepatitis B virus (HBV) and hepatitis ...
The prevalence of chronic HBV infection declined over time, particularly in children younger than 5 years, since the introduction of hepatitis B vaccination. HBV-related death rates also decreased, but HBV-related death counts increased as a result of population growth, ageing, and cohort effects. By 2019, many countries had met the interim seroprevalence target for children younger than 5 ...
Abstract. Hepatitis B virus (HBV) is a non-cytopathic, hepatotropic virus with the potential to cause a persistent infection, ultimately leading to cirrhosis and hepatocellular carcinoma. Over the ...
Chronic hepatitis B virus (HBV) infection affects about 296 million people worldwide and is the leading aetiology of cirrhosis and liver cancer globally. ... Breakthroughs in hepatitis C research ...
Background: The hepatitis B virus (HBV) affects an estimated 290 million individuals worldwide and is responsible for approximately 900 000 deaths annually, mostly from complications of cirrhosis and hepatocellular carcinoma. Although current treatment is effective at preventing complications of chronic hepatitis B, it is not curative, and often must be administered long term.
1. Introduction. Hepatitis B virus (HBV) infection remains a major health problem despite an extensive vaccination program worldwide. Globally, 260 million people are chronically infected with HBV and 890,000 are dying yearly from complications due to the advancement of HBV infection [1,2].HBV may play a role in the pathogenesis of chronic liver disease, cirrhosis, and hepatocellular carcinoma ...
Wen-Juei Jeng, George V Papatheodoridis, Anna S F Lok. Hepatitis B virus (HBV) infection is a major public health problem, with an estimated 296 million people chronically infected and 820 000 deaths worldwide in 2019. Diagnosis of HBV infection requires serological testing for HBsAg and for acute infection additional testing for IgM hepatitis ...
For Thomas Tu, eliminating hepatitis B is a deeply personal goal. Tu, a molecular virologist at the Westmead Institute for Medical Research in Sydney, Australia, learnt he had chronic hepatitis B ...
Author summary The Global Hepatitis Health Sector Strategy is aiming for the elimination of viral hepatitis as a public health threat by 2030. However, mutations associated with drug resistance and vaccine escape may reduce the success of existing treatment and prevention strategies. In the current literature, the prevalence, distribution and impact of hepatitis B virus (HBV) mutations in many ...
Hepatitis B Foundation releases white paper calling health care providers into action following new hepatitis B screening and vaccination recommendations ; ... Anonymous donor provides record gift for hepatitis B research; Two hepatitis B medications available free through Hepatitis B Foundation and Rx Outreach partnership;
Hepatitis B virus is an infectious agent that causes hepatitis B, a type of liver inflammation in humans. A vaccine exists against this virus species. Latest Research and Reviews
Background Hepatitis B virus (HBV) is a highly contagious pathogen that has become a severe public health problem and a major cause of morbidity and mortality, particularly in developing countries. Medical students are at high occupational risk during their training. However, no facility-based studies were found among medical students in eastern Ethiopia. Thus, this study aimed to investigate ...
The HBV cure research agenda outlined in this position paper will contribute markedly to the goal of eliminating HBV infection worldwide. ... Despite the huge human and economic toll of chronic hepatitis B, 2 HBV research remains largely underfunded, 5 to the point of recently being compared to a neglected tropical disease. 6 Given recent ...
Hepatitis B infections are a major cause of hepatocellular carcinoma (HCC), which kills more than 700,000 people globally every year. The virus drives cancer by rearranging human chromosomes ...